Vertex Pharmaceuticals Inc Asset Turnover Ratio (VRTX), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Vertex Pharmaceuticals Inc  (NASDAQ: VRTX)
 

Vertex Pharmaceuticals Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Vertex Pharmaceuticals Inc's asset turnover ratio has remained unchanged compare to previous quarter at 0.48 in the second quarter (Jun 30 2026)

Within sector 74 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2026 compared to the preceding quarter from 1211 to 2019.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VRTX Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Asset Change 14.09 % 15.75 % 36.05 % 34.12 % 38.31 %
Y / Y Revenue Change 12.45 % 7.82 % 9.55 % 10.99 % 12.06 %
Asset Turnover Ratio (TTM) 0.48 0.48 0.49 0.52 0.54
VRTX's Total Ranking # 2019 # 1211 # 1831 # 1749 # 1861
Seq. Asset Change 3.55 % 3.28 % 3.14 % 3.43 % 5.05 %
Seq. Revenue Change 11.62 % -6.37 % 3.69 % 3.77 % 7.02 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 75
Healthcare Sector # 289
Overall Market # 2019

Asset Turnover Ratio Statistics
High Average Low
0.77 0.55 0.26
(Dec 31 2017)   (Dec. 30, 2014)




VRTX Company Profile • Back to VRTX Efficiency Comparisons • Compare VRTX Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Electromed Inc   1.24 $ 72.076  Millions$ 58.289  Millions
Rockwell Medical inc   1.22 $ 69.827  Millions$ 57.145  Millions
Ardent Health Inc   1.22 $ 6,405.940  Millions$ 5,244.371  Millions
Docgo Inc   1.22 $ 294.721  Millions$ 241.732  Millions
Henry Schein Inc   1.21 $ 13,602.000  Millions$ 11,249.250  Millions
Inogen Inc   1.20 $ 354.304  Millions$ 294.283  Millions
Nuwellis Inc   1.19 $ 9.013  Millions$ 7.547  Millions
Angiodynamics Inc   1.18 $ 317.726  Millions$ 268.407  Millions
Myriad Genetics Inc   1.17 $ 805.900  Millions$ 686.825  Millions
Universal Health Services Inc   1.16 $ 18,114.487  Millions$ 15,622.036  Millions
Polomar Health Services, Inc.  1.15 $ 3.172  Millions$ 2.748  Millions
Sunshine Biopharma Inc   1.15 $ 35.347  Millions$ 30.782  Millions
Natera Inc   1.14 $ 2,707.077  Millions$ 2,372.930  Millions
Elite Pharmaceuticals Inc   1.14 $ 140.130  Millions$ 122.899  Millions
Mettler toledo International Inc   1.13 $ 4,133.875  Millions$ 3,643.493  Millions
Mimedx Group Inc   1.13 $ 354.086  Millions$ 312.829  Millions
Cue Biopharma Inc   1.11 $ 37.654  Millions$ 33.860  Millions
Axsome Therapeutics Inc   1.10 $ 776.569  Millions$ 708.527  Millions
Treace Medical Concepts Inc   1.09 $ 205.307  Millions$ 188.082  Millions
Milestone Scientific Inc   1.09 $ 8.855  Millions$ 8.151  Millions
Phibro Animal Health Corporation  1.07 $ 1,516.861  Millions$ 1,423.196  Millions
Nrc Health  1.03 $ 139.996  Millions$ 135.327  Millions
Alphatec Holdings Inc   1.03 $ 814.780  Millions$ 792.240  Millions
Eton Pharmaceuticals Inc   1.03 $ 105.279  Millions$ 102.535  Millions
Addus Homecare Corp  1.03 $ 1,475.610  Millions$ 1,438.108  Millions
National Vision Holdings Inc   1.02 $ 2,033.426  Millions$ 1,986.531  Millions
Omada Health Inc   1.01 $ 308.445  Millions$ 305.974  Millions
Hims and Hers Health Inc   1.00 $ 2,578.494  Millions$ 2,570.967  Millions
Ensign Group Inc  1.00 $ 5,486.708  Millions$ 5,512.641  Millions
Corcept Therapeutics Inc  0.99 $ 830.813  Millions$ 840.960  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.